Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World heart stent study launches to see how it performs outside the lab

NCT ID NCT03967158

Knowledge-focused Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is watching 2,000 people who received the Xience Sierra stent for blocked heart arteries. Researchers want to see how often serious heart problems like death, heart attack, or needing another procedure happen in real life. The goal is to compare this stent's safety and effectiveness with other stents used in daily practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,000 people

The number who actually took part.

Started

Dec 2019

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient with Xience Sierra coronary stent

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 19 and more * Patient with Xience Sierra Everolimus eluting coronary stent * Written consent Exclusion Criteria: * Intervention with Xience Sierra Everolimus eluting coronary stent and other drug eluting stent at the same time * Life-expectancy less than 1 year * Cardiac shock

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Coronary disease

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

  • Dong-A Medical Center

    Busan, South Korea

  • Gangneung Asan Hospital

    Gangneung, South Korea

  • Gangwon National Univ. Hospital

    Chuncheon, South Korea

  • Inje University Busan Paik Hospital

    Busan, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • St.carollo Hospital

    Suncheon, South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea, Yeouido St. Mary's Hospital

    Seoul, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.